Displaying 171 - 180 of 628
Blood Cancer Quality of Life Grant
Updated:
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Blood Cancer Quality of Life Grant Competition.
Image
Lymphoplasmacytic Lymphoma (LPL) and Waldenstrom Macroglobulinemia (WM)
Updated:
Lymphoplasmacytic lymphoma (LPL) and its related condition, Waldenström macroglobulinemia (WM), are slow-growing subtypes of non-Hodgkin lymphoma.
Lymphoma
Follicular Lymphoma
Updated:
Learn more about follicular lymphoma and the resources we have available.
Myelofibrosis (MF)
Updated:
Learn more about myelofibrosis (MF) and the resources we have available.
Diffuse large B-cell Lymphoma (DLBCL)
Updated:
Learn more about diffuse large B-cell lymphoma and the resources we have available.
Halifax Connect & Learn event for the regional blood cancer community
Updated:
Members of the Atlantic Canada blood cancer community came together on September 27, 2025 to learn from healthcare experts and individuals with lived experience.
Funding gaps in blood cancer research to best meet the needs of Canadians
Updated:
Learn about the latest round of blood cancer research funding by the Leukemia & Lymphoma Society of Canada.
Improving drug access in Canada
Updated:
At LLSC, we believe that access to blood cancer treatment means getting the right treatment to the right person at the right time – wherever you live in Canada.
Current and past funded research
Updated:
Learn more about current and past blood cancer research investments by LLSC.
Image
Chronic Lymphocytic Leukemia (CLL) Treatment Discussion Guide
Updated:
Beyond active surveillance (the ‘watch and wait approach’) there are several CLL treatments to consider. Each treatment has different features and side effects. It is important to be comfortable with the CLL treatment you choose.
Leukemia